Tralokinumab Improves Signs and Symptoms of Moderate-to-Severe Atopic Dermatitis in Patients Aged 12 years and Older With and Without Atopic Comorbidities. J of Skin [Internet]. 2024 Jan. 16 [cited 2025 May 18];8(1):s322. Available from: https://skin.dermsquared.com/skin/article/view/2406